Deutsche Bank Ag\ Oncorus, Inc. Transaction History

Deutsche Bank Ag\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.04 - $1.86 $128,684 - $230,147	-123,735 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.44 - $5.62 $45,794 - $178,727	31,802 Added 34.59%	123,735 $220,000
Q4 2021 Feb 11, 2022	SELL	$5.03 - $11.63 $457,307 - $1.06 Million	-90,916 Reduced 49.72%	91,933 $484,000
Q3 2021 Nov 04, 2021	SELL	$9.29 - $14.27 $2.59 Million - $3.98 Million	-278,570 Reduced 60.37%	182,849 $1.71 Million
Q2 2021 Aug 11, 2021	BUY	$13.3 - $17.3 $6.08 Million - $7.91 Million	457,177 Added 10777.39%	461,419 $6.37 Million
Q1 2021 May 13, 2021	SELL	$11.89 - $35.55 $4,815 - $14,397	-405 Reduced 8.72%	4,242 $59,000
Q4 2020 Feb 16, 2021	BUY	$15.0 - $35.15 $69,705 - $163,342	4,647 New	4,647 $150,000

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.